New study of 134,899 patients on PAP therapy shows those with treatment-emergent CSA are nearly two times more likely to terminate therapy.
The ResMed Academy Online is designed to provide you with easy access to a variety of learning resources at no cost.
New User? Register here
Already a member? Log in here